Astrana Health (NASDAQ:ASTH) Trading Down 3.6% - Time to Sell?

Key Points

• Astrana Health (NASDAQ:ASTH) saw a 3.6% drop in trading on Wednesday, with shares traded at $30.74, significantly below its previous close of $31.88.
• Zacks Research downgraded the company from a "strong-buy" to a "strong sell" rating, amid mixed analyst opinions resulting in an average rating of "Moderate Buy" with a price target of $53.29.
• The company's latest earnings report revealed a miss on earnings per share at $0.19 compared to the consensus estimate of $0.36, though revenue increased by 34.7% year-over-year.

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) dropped 3.6% during trading on Wednesday . The company traded as low as $30.76 and last traded at $30.74. Approximately 10,709 shares were traded during trading, a decline of 97% from the average daily volume of 337,802 shares. The stock had previously closed at $31.88.

Analyst Ratings Changes

Separately, Zacks Research lowered Astrana Health from a "strong-buy" rating to a "strong sell" rating in a report on Monday. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $53.29.

Astrana Health Trading Down 5.0%

The stock has a market cap of $1.70 billion, a P/E ratio of 59.48, a P/E/G ratio of 0.79 and a beta of 0.85. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59. The company has a 50-day simple moving average of $26.15 and a 200-day simple moving average of $28.31.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.36 by ($0.17). The firm had revenue of $654.81 million for the quarter, compared to the consensus estimate of $639.13 million. Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The company's revenue was up 34.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.40 EPS. Astrana Health has set its Q3 2025 guidance at EPS. On average, sell-side analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

A number of institutional investors have recently made changes to their positions in ASTH. Covestor Ltd grew its stake in shares of Astrana Health by 777.6% during the first quarter. Covestor Ltd now owns 2,001 shares of the company's stock worth $62,000 after purchasing an additional 1,773 shares during the period. Tower Research Capital LLC TRC grew its stake in shares of Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company's stock worth $115,000 after purchasing an additional 3,517 shares during the period. State of Wyoming acquired a new stake in shares of Astrana Health during the second quarter worth $132,000. AlphaQuest LLC grew its stake in shares of Astrana Health by 144.2% during the first quarter. AlphaQuest LLC now owns 4,883 shares of the company's stock worth $151,000 after purchasing an additional 2,883 shares during the period. Finally, US Bancorp DE grew its stake in shares of Astrana Health by 21.3% during the first quarter. US Bancorp DE now owns 5,791 shares of the company's stock worth $180,000 after purchasing an additional 1,015 shares during the period. 52.77% of the stock is owned by institutional investors and hedge funds.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.